Oxynorm (Oxycodone Hydrochloride)

Oxycodone hydrochloride, the active ingredient in Oxynorm, is an opioid analgesic presented as a oral formulation for systemic use. It is prescribed for the management of moderate to severe pain in adult patients when other analgesics are insufficient. GNH USA supplies Oxynorm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Oxynorm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Oxynorm is an opioid analgesic that acts on the central nervous system to relieve pain in several clinical contexts.

- Acute postoperative pain: provides rapid relief following surgical procedures. - Cancer‑related pain: helps control persistent pain associated with malignant disease. - Severe chronic non‑cancer pain: used when other treatments have not achieved adequate control.

Adverse reactions may range from mild to life‑threatening and should be monitored during therapy.

Common Side Effects: - Constipation: reduced gastrointestinal motility. - Nausea and vomiting: upset stomach and emesis. - Drowsiness: increased sedation and reduced alertness. - Dry mouth: decreased salivary flow. - Dizziness: light‑headed sensation, especially when standing. - Pruritus: mild itching of the skin.

Serious or Rare Side Effects: - Respiratory depression: slowed or shallow breathing that can be fatal. - Severe hypotension: marked drop in blood pressure. - Opioid use disorder: risk of dependence, tolerance, and addiction. - Seizures: rare occurrence of convulsive episodes. - Anaphylaxis: acute allergic reaction with airway compromise. - adrenal insufficiency: rare hormonal imbalance affecting stress response.

When prescribing Oxynorm, clinicians should evaluate patient history and monitor for potential complications.

- Assess renal and hepatic function: adjust use if impairment is present. - Evaluate respiratory status: avoid in patients with compromised breathing. - Review concomitant CNS depressants: increased sedation risk. - Counsel on constipation management: use laxatives or stool softeners as needed. - Monitor for signs of dependence or misuse: educate patients on safe use. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Oxynorm can interact with several drug classes, altering its efficacy or safety profile.

Major Interactions (Avoid): - Benzodiazepines: combined central nervous system depression can be fatal. - Barbiturates: additive respiratory depression risk. - Muscle relaxants: heightened sedative effects. - Alcohol: synergistic depressant effect on respiration and cognition. - CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): increase oxy‑c‑tolerance.

Moderate Interactions (Monitor Closely): - CYP2D6 inhibitors (e.g., fluoxetine, paroxetine): may alter metabolism. - Anticholinergic agents: may worsen constipation. - Diuretics: potential for orthostatic hypotension. - Antihistamines: increased drowsiness. - NSAIDs: heightened risk of gastrointestinal bleeding.